Apyx Medical (APYX) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Apyx Medical | 174.53 Mn | 143.65 Mn | 7.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.76% |
| Dec 31, 2025 | 5.52% |
| Sep 30, 2025 | 10.51% |
| Jun 30, 2025 | 8.81% |
| Mar 31, 2025 | 9.68% |
| Dec 31, 2024 | 11.67% |
| Sep 30, 2024 | 14.86% |
| Jun 30, 2024 | 13.56% |
| Mar 31, 2024 | 12.75% |
| Dec 31, 2023 | 11.11% |
| Sep 30, 2023 | 25.64% |
| Jun 30, 2023 | -18.42% |
| Mar 31, 2023 | -13.08% |
| Dec 31, 2022 | -0.05% |
| Sep 30, 2022 | -9.18% |
| Jun 30, 2022 | -13.97% |
| Mar 31, 2022 | -17.65% |
| Dec 31, 2021 | -14.93% |
| Sep 30, 2021 | -26.79% |
| Jun 30, 2021 | -29.78% |
| Mar 31, 2021 | -33.03% |
| Dec 31, 2020 | -27.00% |
| Sep 30, 2020 | -26.54% |
| Jun 30, 2020 | -26.32% |
| Mar 31, 2020 | -26.79% |
| Dec 31, 2019 | -58.16% |
| Sep 30, 2019 | -57.82% |
| Jun 30, 2019 | -64.60% |
| Mar 31, 2019 | -61.30% |
| Dec 31, 2018 | -54.57% |
| Sep 30, 2018 | -107.47% |
| Mar 31, 2018 | -18.26% |
| Dec 31, 2017 | -15.33% |
| Sep 30, 2017 | -15.96% |
| Jun 30, 2017 | -15.61% |
| Mar 31, 2017 | -22.81% |
| Dec 31, 2016 | -25.57% |
| Sep 30, 2016 | -11.52% |
| Jun 30, 2016 | -10.29% |
| Mar 31, 2016 | -16.25% |
| Dec 31, 2015 | -27.00% |